Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 29

1.

Cinacalcet, Fibroblast Growth Factor-23, and Cardiovascular Disease in Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial.

Moe SM, Chertow GM, Parfrey PS, Kubo Y, Block GA, Correa-Rotter R, Drüeke TB, Herzog CA, London GM, Mahaffey KW, Wheeler DC, Stolina M, Dehmel B, Goodman WG, Floege J; Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial Investigators*.

Circulation. 2015 Jul 7;132(1):27-39. doi: 10.1161/CIRCULATIONAHA.114.013876. Epub 2015 Jun 9.

2.

The Effects of Cinacalcet in Older and Younger Patients on Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial.

Parfrey PS, Drüeke TB, Block GA, Correa-Rotter R, Floege J, Herzog CA, London GM, Mahaffey KW, Moe SM, Wheeler DC, Kubo Y, Dehmel B, Goodman WG, Chertow GM; Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial Investigators.

Clin J Am Soc Nephrol. 2015 May 7;10(5):791-9. doi: 10.2215/CJN.07730814. Epub 2015 Feb 20.

3.

Diet and kidney disease in high-risk individuals with type 2 diabetes mellitus.

Dunkler D, Dehghan M, Teo KK, Heinze G, Gao P, Kohl M, Clase CM, Mann JF, Yusuf S, Oberbauer R; ONTARGET Investigators.

JAMA Intern Med. 2013 Oct 14;173(18):1682-92.

PMID:
23939297
4.

Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis.

EVOLVE Trial Investigators, Chertow GM, Block GA, Correa-Rotter R, Drüeke TB, Floege J, Goodman WG, Herzog CA, Kubo Y, London GM, Mahaffey KW, Mix TC, Moe SM, Trotman ML, Wheeler DC, Parfrey PS.

N Engl J Med. 2012 Dec 27;367(26):2482-94. doi: 10.1056/NEJMoa1205624. Epub 2012 Nov 3.

5.

Associations of plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D concentrations with death and progression to maintenance dialysis in patients with advanced kidney disease.

Kendrick J, Cheung AK, Kaufman JS, Greene T, Roberts WL, Smits G, Chonchol M; HOST (Homocysteinemia in Kidney and End Stage Renal Disease) Study Investigators.

Am J Kidney Dis. 2012 Oct;60(4):567-75. doi: 10.1053/j.ajkd.2012.04.014. Epub 2012 May 22.

6.

Medication adherence assessment in a clinical trial with centralized follow-up and direct-to-patient drug shipments.

Warren SR, Raisch DW, Campbell HM, Guarino PD, Kaufman JS, Petrokaitis E, Goldfarb DS, Gaziano JM, Jamison RL; Veterans Affairs Site Investigators.

Clin Trials. 2013;10(3):441-8. doi: 10.1177/1740774511410331. Epub 2011 Aug 3.

PMID:
21813583
7.

Novel H1N1-associated rhabdomyolysis leading to acute renal failure.

Parikh M, Dolson G, Ramanathan V, Sangsiraprapha W.

Clin Microbiol Infect. 2010 Apr;16(4):330-2. doi: 10.1111/j.1469-0691.2010.03185.x. Epub 2010 Feb 2.

8.

Intensity of renal support in critically ill patients with acute kidney injury.

VA/NIH Acute Renal Failure Trial Network, Palevsky PM, Zhang JH, O'Connor TZ, Chertow GM, Crowley ST, Choudhury D, Finkel K, Kellum JA, Paganini E, Schein RM, Smith MW, Swanson KM, Thompson BT, Vijayan A, Watnick S, Star RA, Peduzzi P.

N Engl J Med. 2008 Jul 3;359(1):7-20. doi: 10.1056/NEJMoa0802639. Epub 2008 May 20. Erratum in: N Engl J Med. 2009 Dec 10;361(24):2391.

9.

Lessons for successful study enrollment from the Veterans Affairs/National Institutes of Health Acute Renal Failure Trial Network Study.

Crowley ST, Chertow GM, Vitale J, O'Connor T, Zhang J, Schein RM, Choudhury D, Finkel K, Vijayan A, Paganini E, Palevsky PM; VA/NIH Acute Renal Failure Trial Network Study Group.

Clin J Am Soc Nephrol. 2008 Jul;3(4):955-61. doi: 10.2215/CJN.05621207. Epub 2008 Apr 2.

10.

Telmisartan, ramipril, or both in patients at high risk for vascular events.

ONTARGET Investigators, Yusuf S, Teo KK, Pogue J, Dyal L, Copland I, Schumacher H, Dagenais G, Sleight P, Anderson C.

N Engl J Med. 2008 Apr 10;358(15):1547-59. doi: 10.1056/NEJMoa0801317. Epub 2008 Mar 31.

11.

Healthcare costs associated with hemodialysis catheter-related infections: a single-center experience.

Ramanathan V, Chiu EJ, Thomas JT, Khan A, Dolson GM, Darouiche RO.

Infect Control Hosp Epidemiol. 2007 May;28(5):606-9. Epub 2007 Apr 12.

PMID:
17464925
12.

Acute renal failure due to tumor lysis syndrome in a HIV seropositive patient with Castleman's disease.

Ralph R, Adrogue HE, Dolson G, Ramanathan V.

Nephrol Dial Transplant. 2004 Jul;19(7):1937. No abstract available.

PMID:
15199211
13.

Incidence and consequences of total body potassium depletion in chronic hemodialysis patients.

Dolson GM, Ellis KJ, Johnson ML, Adrogué HJ.

Front Biosci. 2003 May 1;8:a126-32.

PMID:
12700088
14.

Low dialysate [K+] decreases efficiency of hemodialysis and increases urea rebound.

Dolson GM, Adrogué HJ.

J Am Soc Nephrol. 1998 Nov;9(11):2124-8.

15.

Endothelin-1 increases rat distal tubule acidification in vivo.

Wesson DE, Dolson GM.

Am J Physiol. 1997 Oct;273(4 Pt 2):F586-94.

16.
17.
18.

Acute decreases in serum potassium augment blood pressure.

Dolson GM, Ellis KJ, Bernardo MV, Prakash R, Adrogué HJ.

Am J Kidney Dis. 1995 Aug;26(2):321-6.

PMID:
7645536
19.

Rhabdomyolysis and acute renal failure during high-dose haloperidol therapy.

Marsh SJ, Dolson GM.

Ren Fail. 1995 Jul;17(4):475-8.

PMID:
7569118
20.

Identification of GTP-binding proteins in turtle urinary bladder epithelial cells.

Dolson GM, Ribeiro C, Ulate G, Ribeiro-Neto F, Adrogué HJ.

Miner Electrolyte Metab. 1994;20(5):302-8.

PMID:
7700219

Supplemental Content

Loading ...
Support Center